ボロン酸添加によるKPCと他の耐性菌との 鑑別
耐性機序 ホッジ 試験 ボロン酸添加による阻止円の差 エルタペネ ム イミペネ ム メロペネム セフタジジ ム kpc(+) 陽性 6-10(8) 1-7(5) 6-10(8) 0-9(2) kpc(-)の カルバペネム耐
Download ボロン酸添加によるKPCと他の耐性菌との 鑑別
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Advertisement
Documents from same domain
CLSI A One Health Perspective on Susceptibility …
www.jscm.org1 CLSI –A One Health Perspective on Susceptibility Testing Dr. Jeffrey L. Watts, PhD, RM (NRCM), M (ASCP) Director, External Innovation –Anti-Infectives Zoetis, Inc
Health, Perspective, Testing, One health perspective on susceptibility, Susceptibility, One health perspective on susceptibility testing
CT - jscm.org
www.jscm.orgct 6 ˘ˇ ˆ˙˝ ˘ ˛˚ ˜ ˘˚ ! "#$ %& ’( ) *˘ ˇ+,)- .ˆ’(˙/ ˇ˝ ˛ ˚˜ !" 01#234$5
Moraxella osloensis 1 - jscm.org
www.jscm.org4 dna 16s rrna ˘ ˇˆ8ua (5 -agagtttgatcmtggctcag-3 ), 1485b (5 -taccgttaccttgttacgac-3 ) ˙ ˝˛˚˜ pcr ˘ pcr
TRC TRCRapid M. TB - jscm.org
www.jscm.orgpcr n- -a- ˘(nalc) ˇ ˆ ˙84 ˝˛ 67 ˚˛˜ 8 ˚˛!"#$ % 3 ˚˛&’3 ˚˛ 2 ˚˛( )*1 ˚˝ +nalc ˇ ˆ˙,- .˘/01234 (pbs) ˝1,000 ml˛pcr ˙ 5 100 ml˛
バンコマイシン耐性腸球菌 - jscm.org
www.jscm.org10 日本臨床微生物学雑誌 Vol.24 No.3 2014. Ⓒ日本臨床微生物学会2014 [総 説] バンコマイシン耐性腸球菌 富田治芳 1)2)・野村隆浩・久留島潤・谷本弘一2) 1)群馬大学大学院医学系研究科細菌学分野 2)群馬大学大学院医学系研究科附属薬剤耐性菌実験施設 (平成26年7月31日受付)
coagulase-negative staphylococci
www.jscm.org7) 2003. 4: 153 155. 8) Kirchho#,L.V., J. N. Sheagren. 1985. Epidemi-ology and clinical significance of blood cul-tures positive for coagulase-negative staphylo-
Negative, Coagulase negative staphylococci, Coagulase, Staphylococci
Loop-mediated isothermal amplification(LAMP) …
www.jscm.orgLAMP法によるレジオネラ属菌の検出 6×106 CFU/mlおよび約6×108 CFU/mlに希釈し た。これらは95℃で5分間の熱処理後,氷冷して, 12,000 rpm,4℃,10分間の遠心分離を行 …
ƒ⁄‹ˇˆ˙ . 2007 53 - jscm.org
www.jscm.orgAcinetobacter ursingii Nemec et al. 2001 51: 1898 2 Actinobacillus capsula-tus Arseculeratne 1962 30: 241 1980 Class 2 2(t) Actinobacillus delphini-
Fusobacterium necrophorum - jscm.org
www.jscm.orgACase of Retropharyngeal Lymph Node Abscess Which Fusobacterium necrophorum Was Isolated from Blood Culture Keiko Kaiho,1) Naruhiko Ishiwada,1) Haruka Hishiki,1) Masaharu Watanabe,2) Yoichi Kohno1)
広域β-ラクタム薬耐性に関与するβ-ラクタマーゼの …
www.jscm.org荒川宜親 14 日本臨床微生物学雑誌 Vol.13 No.3 2003. 152 までには至っていなかった。しかし,1990年には, プラスミド依存性にCAZに耐性を獲得したKlebsiella
Related documents
Laboratory Detection and Reporting of CRE - XDRO
www.xdro.orgMolecular Class Carbapenemase Found in: Some Key Features A KPC K. pneumoniae and other Enterobacteriaceae Some are chromosomal (NmcA, Sme, IMI-1, SFC-1) others are plasmid encoded
Laboratory, Reporting, Detection, Laboratory detection and reporting of, Carbapenemase
2018 REPORTABLE DISEASES IN MICHIGAN BY CONDITION
www.michigan.gov2018 REPORTABLE DISEASES IN MICHIGAN –BY CONDITION A Guide for Physicians, Health Care Providers and Laboratories Report the following conditions to the Michigan Disease Surveillance System (MDSS) or local health department (see reverse)
INTER-FACILITY INFECTION CONTROL TRANSFER FORM …
www.cdc.govINTER-FACILITY INFECTION CONTROL TRANSFER FORM FOR STATES ESTABLISHING HAI PREVENTION COLLABORATIVES This example Inter-facility Infection Control patient transfer form can assist in fostering communication during transitions
Control, Facility, Transfer, Inter, Infections, Inter facility infection control transfer, Inter facility infection control
Recommendations for the Management of Carbapenem ...
www.health.state.mn.us2/2013 Recommendations for the Management of Carbapenem-Resistant Enterobacteriaceae (CRE) in Acute and Long-term Acute Care Hospitals. Minnesota Department of Health
Management, Resistant, Carbapenem, Enterobacteriaceae, Management of carbapenem resistant enterobacteriaceae
ATENÇÃO(–(OILAS(disponibiliza((esse(guia(apenas(como ...
www.sepsisnet.orgInfecção urinária # # # # Quinolononas ou cefalosporina de terceira geração # # Cefalosporinas de 4a geração ou carbapenêmicos (imipenem ou meropenem)
Traitement systémique des infections à bacilles Gram ...
www.edimark.frT. Ferry 142 | La Lettre de l’Infectiologue •Tome XXVIII - no 4 - juillet-août 2013 TT re Traitement systémique des infections à bacilles Gram négatif producteurs de carbapénémases Treatment of carbapenemase-producing Gram negative
Instructions for C ompletion of the Patient Safety ...
www.cdc.govJanuary 2019 1 . Plan and Annual Surveys Instructions for C ompletion of the Patient Safety Component-Annual Hospital Survey (CDC 57.103) Data Field
Patients, Annual, Safety, Instructions, Component, Hospital, Instructions for c ompletion of the, Ompletion, Instructions for c ompletion of the patient safety component annual hospital
Sample risk factor-based admission form for screening for ...
www.publichealthontario.caSample risk factor-based admission form for screening for MRSA, VRE, ESBL and CPE [adapted from Sunnybrook Health Sciences Centre] This tool is an excerpt from the …
Related search queries
Laboratory Detection and Reporting of, Carbapenemase, INTER-FACILITY INFECTION CONTROL TRANSFER, Inter-facility Infection Control, Management of Carbapenem-Resistant Enterobacteriaceae (CRE) in, Instructions for C ompletion of the, Instructions for C ompletion of the Patient Safety Component-Annual Hospital